Role of bronchoalveolar lavage, transbronchial needle aspiration with bronchial biopsy correlation in lung tumours and immunohistochemistry wherever required

Authors

  • Nazia T. Sheikh Department of Pathology, SKIMS, Srinagar, Jammu and Kashmir, India
  • Zarkah Nabi Department of Pathology, SKIMS, Srinagar, Jammu and Kashmir, India
  • Faizaan Mir Department of Pathology, SKIMS, Srinagar, Jammu and Kashmir, India
  • Parveen Shah Department of Pathology, SKIMS, Srinagar, Jammu and Kashmir, India
  • Zubaida Rasool Department of Pathology, SKIMS, Srinagar, Jammu and Kashmir, India
  • Rafi A. Jan Department of Pulmonary Medicine, SKIMS, Srinagar, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20195892

Keywords:

Bronchial biopsy, Bronchoalveolar lavage, Immunohistochemistry, Lung carcinoma, Transbronchial needle aspiration

Abstract

Background: Lung cancer is most frequently diagnosed major cancer in the world and the most common cause of cancer mortality worldwide. It comprises about 17% of the total new cancer cases in males and 23% of the total cancer deaths. The objectives of this study were to compare bronchial biopsy, BAL and TBNA in diagnosing lung malignancies and IHC wherever required.

Methods: The study was conducted at Sher-i-Kashmir Institute of Medical Sciences Srinagar, India in the department of Pathology. It was a prospective study over a period of 1½ years from June 2015 to December 2016. All patients clinically/ radiologically suspected of lung malignancies who presented between June 2015 to December 2016 and underwent bronchial biopsy, BAL (washings) and TBNA were included in the study. The study included only those cases where BAL, TBNA and bronchial biopsy were done simultaneously.

Results: Out of a total 117 clinically suspected cases of lung cancer, tumor was found in 103 cases (103/117) by biopsy, 51 cases by BAL (51/117) and 64 cases by TBNA (64/117). The total number of false positive cases and false negative cases by BAL were 6 and 58. Sensitivity of BAL was found to be 43.69% and specificity 57.14%. The total number of false positive cases and false negative cases by TBNA were 7 and 46. Sensitivity and specificity of TBNA was found to be 55.34% and 50.0%.

Conclusions: Thus, in the present study yield of diagnosis was highest with the bronchoscopic biopsies and in maximum number of cases with a sensitivity of 88.034%, and specific histologic diagnosis was made by biopsies and IHC only. Though BAL and TBNA were inferior to bronchial biopsy in diagnosing lung malignancies but these were effective for peripheral lung malignancies and when the patient was at risk of haemorrhage.

References

Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Resp J. 2001 Dec 1;18(6):1059-68.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a Cancer J Clin. 2011 Mar;61(2):69-90.

Edell ES, Cortese DA. Bronchoscopic localization and treatment of occult lung cancer. Chest. 1989 Oct 1;96(4):919-21.

Chaudhry MK, Rasul S, Iqbal ZH. Fiberoptic bronchoscopy - role in the diagnosis of bronchogenic carcinoma. Biomedica. 1998;14:32-6.

Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Nation Cancer Inst. 1999 Apr 21;91(8):675-90.

Shure D, Astarita RW. Bronchogenic carcinoma presenting as an endobronchial mass: optimal number of biopsy specimens for diagnosis. Chest. 1983 Jun 1;83(6):865-7.

Popovich Jr J, Kvale PA, Eichenhorn MS, Radke JR, Ohorodnik JM, Fine G. Diagnostic accuracy of multiple biopsies from flexible fiberoptic bronchoscopy: a comparison of central versus peripheral carcinoma. Am Rev Resp Dis. 1982 May;125(5):521-3.

Naryshkin S, Daniels J, Young NA. Diagnostic correlation of fiberoptic bronchoscopic biopsy and bronchoscopic cytology performed simultaneously. Diag Cytopathol. 1992 Mar;8(2):119-23.

Debeljak A, Mermolja M, Šorli J, Zupančič M, Zorrnan M, Remškar J. Bronchoalveolar lavage in the diagnosis of peripheral primary and secondary malignant lung tumors. Respiration. 1994;61(4):226-30.

Rasool MT, Lone MM, Wani ML, Afroz F, Zaffar S, Haq MM. Cancer in Kashmir, India: burden and pattern of disease. J Cancer Res Therap. 2012 Apr 1;8(2):243.

Shah A, Jan GM. Pattern of cancer at Srinagar (Kashmir). Ind J Pathol Microbiol. 1990 Apr;33(2):118-23.

Dhar GM, Shah GN, Naheed B. Epidemiological trend in the distribution of cancer in Kashmir Valley. J Epidemiol Commun Health. 1993 Aug 1;47(4):290-2.

ICMR. Cancer incidence and leading sites of cancer in population-based cancer registries: development of an atlas of cancer in India. ICMR, First AIR 2001-2002;11-8.

Robert P, Baaghman. Bronchoscopy, lung biopsy and other diagnostic procedures In. Murray. Nadel. Mason. Boushey Textbook of Respiratory Medicine- 3rd ed. United States of America.W.B. Saunders company.2000;725-728.

Tockman MS, Mulshine JL, Piantadosi S, Erozan YS, Gupta PK, Ruckdeschel JC, et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res. 1997 Dec 1;3(12):2237-46.

Khan NA, Afroz F, Lone MM, Teli MA, Muzaffar M, Jan N. Profile of lung cancer in Kashmir, India: a five-year study. Small. 2006 Jul;55:17.

Ikeda S, Yanai N, Ishikawa S. Flexible bronchofiberscope. Keio J Med. 1968;17(1):1-6.

Fuladi AB, Munje RP, Tayade BO. Value of washings, brushings, and biopsy at fibreoptic bronchoscopy in the diagnosis of lung cancer. J Ind Acad Clin Med. 2004 Apr;5(2):137-42.

Gupta D, Boffetta P, Gaborieau V, Jindal SK. Risk factors of lung cancer in Chandigarh, India. Ind J Med Res. 2001 Apr 1;113:142.

Kvale PA, Bode LF, Kini S. Diagnostic accuracy in lung cancer: comparison of techniques used in association with flexible fiberoptic bronchoscopy. Chest. 1976 Jun 1;69(6):752-7.

Gaur DS, Thapliyal NC, Kishore S, Pathak VP. Efficacy of broncho-alveolar lavage and bronchial brush cytology in diagnosing lung cancers. J Cytol. 2007 Apr 1;24(2):73.

Poletti V, Poletti G, Murer B, Saragoni L, Chilosi MM. Bronchoalveolar Lavage. Semin Respir Crit Care Med. 2007;28:534-45.

Koul PA, Kaul SK, Sheikh MM, Tasleem RA, Shah A. Lung cancer in the Kashmir valley. Lung Ind: Offici Organ Ind Chest Soci. 2010 Jul;27(3):131.

Bhat N, Nazeir MJ, Bashir H, Bashir N, Farooq S, Fatima K, et al. Correlation of bronchial biopsy with bronchoalveolar lavage in lung malignancies. Int J Res Med Sci. 2016 Feb;4(2):428-35.

Tournoy KG, Rintoul RC, van Meerbeeck JP, Carroll NR, Praet M, Buttery RC, et al. EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy. Lung Cancer. 2009 Jan 1;63(1):45-9.

Downloads

Published

2019-12-25

How to Cite

Sheikh, N. T., Nabi, Z., Mir, F., Shah, P., Rasool, Z., & Jan, R. A. (2019). Role of bronchoalveolar lavage, transbronchial needle aspiration with bronchial biopsy correlation in lung tumours and immunohistochemistry wherever required. International Journal of Research in Medical Sciences, 8(1), 109–118. https://doi.org/10.18203/2320-6012.ijrms20195892

Issue

Section

Original Research Articles